2026-08-13T12:16:20-05:00 2025-12-31 481142819 BRIDGEBUILDER TAX AND LEGAL SERVICES PA 9325 PFLUMM RD LENEXA KS 66215 990 2025-01-01 042720360 ACCP FOUNDATION LTD PHAR 9134923311 13000 WEST 87TH STREET PARKWAY LENEXA KS 66215 MICHAEL S MADDUX PHARM D FCCP DIRECTOR 9134923311 2026-08-13 1 BRIAN G SCOTT P01605333 9134926008 2025 2025-03-06 01:10:19Z MICHAEL S MADDUX PHARM 13000 WEST 87TH STREET PARKWAY LENEXA KS 66215 968388 0 X WWW.ACCPFOUNDATION.ORG X 1981 MA ADVANCE HUMAN HEALTH BY SUPPORTING AND DISSEMINATING PHARMACOTHERAPEUTIC AND CLINICAL PHARMACY RESEARCH, SCHOLARSHIP, AND PRACTICE INNOVATION. 9 8 0 483 0 0 127510 432998 391849 365762 129195 134767 0 20430 648554 953957 94047 218916 0 0 13513 206832 0 0 12375 473703 491695 581263 917443 67291 36514 5236664 5636598 229370 173967 5007294 5462631 ADVANCE HUMAN HEALTH BY SUPPORTING AND DISSEMINATING PHARMACOTHERAPEUTIC AND CLINICAL PHARMACY RESEARCH, SCHOLARSHIP, AND PRACTICE INNOVATION. 0 0 454528 371761 SUBSCRIPTION SUPPLEMENTS AND PUBLICATION SUBSCRIPTIONS - ORGANIZATION PUBLISHES TWO SCIENTIFIC JOURNALS THAT CONTAIN CLINICAL RESEARCH ARTICLES AND PROVIDE EVALUATION OF DRUGS AND DRUG TREATMENTS. 218916 218916 RESEARCH GRANTS - PROVIDE RESEARCH GRANTS AND AWARDS TO SUPPORT CLINICAL PHARMACY RESEARCH. 673444 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 23 0 0 0 0 0 0 0 0 0 0 0 0 X 9 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 MA X X ACCP FOUNDATION LTD 9134923311 13000 WEST 87TH STREET PARKWAY LENEXA KS 66215 JAMES E TISDALE PHARM D FCCP BCPS CHAIR 2.00 X X 0 0 0 MICHAEL S MADDUX PHARM D FCCP EX OFFICIO MEMBER 1.00 40.00 X 0 0 0 WILLIAM A MILLER PHARM D FCCP DIRECTOR 1.00 X 2500 0 0 C LINDSAY DEVANE PHARM D FCCP EX OFFICIO MEMBER 1.00 X 0 0 0 KERI A SIMS PHARM D BCPS CAE SECRETARY 30.00 10.00 X X 137205 58802 11892 TITILOLA M AFOLABI PHARMD FCCP DIRECTOR 1.00 X 0 0 0 KELLY E CAUDLE PHARMD PHD FCC DIRECTOR 1.00 X 0 0 0 CANDICE L GARWOOD PHARMD FCCP B EX OFFICIO DIRECTOR 1.00 X 0 0 0 MARC H SCHEETZ PHARMD FCCP TREASURER 1.00 X X 0 0 0 KATIE J SUDA PHARMD FCCP DIRECTOR 1.00 X 0 0 0 MARK S SHAEFER DIRECTOR 1.00 X 0 0 0 STUART T HAINES JACCP EDITOR-IN-CHI EX OFFICIO DIRECTOR 1.00 X 0 0 0 SHELDON G HOLSTAD PHARMD ASSOC. EXE DIRECTOR 8.00 32.00 X 63315 253261 36682 203020 312063 48574 1 0 1 0 0 172578 260420 432998 SUBSCRIPTION CONTRACT 611430 268812 268812 WILEY AGREEMENT 513120 96950 96950 365762 149198 149198 14431 -14431 -14431 -14431 0 172578 0 0 RETURN OF UNUSED GRANT 900099 20430 20430 20430 953957 371761 0 149198 X 218916 218916 188836 84977 103859 17996 8098 9898 8923 8923 10000 10000 9792 9792 418226 329581 84422 4223 759 759 934 934 3037 3037 MERIT 16495 16495 FIT 15377 15377 FUNDRAISING 8152 8152 917443 673444 231624 12375 718763 318519 14524 16500 7995 2586 4503377 5290998 5236664 5636598 229370 173967 229370 173967 X 4983065 5431824 24229 30807 5007294 5462631 5236664 5636598 36514 418823 0 X 0 1 X 1 0 X 127510 432998 560508 333814 390584 376137 391849 365762 1858146 333814 390584 376137 519359 798760 2418654 102136 275155 377291 0 102136 275155 377291 2041363 30786 35573 38190 59527 149198 313274 30786 35573 38190 59527 149198 313274 364600 426157 414327 578886 947958 2731928 0.74720 0.86170 0.11470 0.09090 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 X 1342559 418823 418823 923736 9791 20430 30221 953957 887222 0 887222 9791 20430 30221 917443 PART X, LINE 2: THE ORGANIZATION IS EXEMPT FROM INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS THEREFORE EXEMPT FROM FEDERAL INCOME TAXES. THE ORGANIZATION IS SUBJECT TO INCOME TAXES ON ALL UNRELATED BUSINESS INCOME. UNCERTAIN TAX PROVISIONS, IF ANY, ARE RECORDED IN ACCORDANCE WITH FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) ACCOUNTING STANDARDS CODIFICATION (ASC) 740, INCOME TAXES, WHICH REQUIRE THE RECOGNITION OF A LIABILITY FOR TAX POSITIONS TAKEN THAT DO NOT MEET THE MORE-LIKELY-THAN-NOT STANDARD THAT THE POSITION WILL BE SUSTAINED UPON EXAMINATION BY THE TAXING AUTHORITIES. THERE IS NO LIABILITY FOR UNCERTAIN TAX POSITIONS RECORDED AT DECEMBER 31, 2025 AND 2024. THE ORGANIZATION'S INCOME TAX FILINGS ARE SUBJECT TO EXAMINATION BY VARIOUS TAXING AUTHORITIES. THE ORGANIZATION'S OPEN EXAMINATION PERIODS ARE 2022 AND FORWARD. PART XI, LINE 4B - OTHER ADJUSTMENTS: RETURN OF UNUSED GRANT FUNDS 20,430. PART XII, LINE 4B - OTHER ADJUSTMENTS: RETURN OF UNUSED GRANT FUNDS 20,430. FRONTIER FUND 172578 172578 172578 172578 1 THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS 506 S WRIGHT ST URBANA IL 61801 376000511 0 20580 FMV GRANTS AND AWARDS BSW DALLAS FOUNDATION 301 N WASHINGTON AVE DALLAS TX 75246 751606705 0 80000 FMV GRANTS AND AWARDS UNIVERSITY OF UTAH 201 S PRESIDENTS CIRCLE RM 159 SALT LAKE CITY UT 84112 876000525 0 19625 FMV GRANTS AND AWARDS MONTEFIORE MEDICAL CENTER 111 E 210TH ST BRONX NY 10467 131740114 0 50000 FMV GRANTS AND AWARDS REGENTS OF THE UNIVERSITY OF MINNESOTA PO BOX 1450 MINNEAPOLIS MN 55485 416007513 0 48711 FMV GRANTS AND AWARDS 0 0 0 0 0 0 0 0 0 SHELDON G HOLSTAD PHARMD ASSOC. EXE DIRECTOR 63315 253261 0 0 0 0 34999 0 1683 0 99997 253261 0 0 KERI A SIMS PHARM D BCPS CAE SECRETARY 137205 58802 0 0 0 0 10137 0 1755 0 149097 58802 0 0 FORM 990, PART VI, SECTION B, LINE 11B ORGANIZATION'S PROCESS TO REVIEW FORM 990: THE RETURN WILL BE REVIEWED BY THE FULL BOARD OF DIRECTORS. A COPY OF THE RETURN WILL BE MAINTAINED FOR PUBLIC INSPECTION. FORM 990, PART VI, SECTION B, LINE 12C ANY POTENTIAL AUTHOR, EDITOR, EDITORIAL BOARD MEMBER, REVIEWER, OR CONTRIBUTOR TO AN ACCP FOUNDATION PUBLICATION OR PROGRAM WILL BE EVALUATED TO DETERMINE WHETHER THE POTENTIAL FOR EXCESSIVE REAL OR PERCEIVED CONFLICT OF INTEREST EXISTS. IF THIS EVALUATION DETERMINES THAT CONFLICT OF INTEREST DOES EXIST, THAT INDIVIDUAL WILL BE EXCUSED FROM DUTY OR PARTICIPATION IN THAT PROJECT. FORM 990, PART VI, SECTION C, LINE 19 GOVERNING DOCUMENTS ARE AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST AND POSTED ON THE SECRETARY OF STATE WEBSITE OF THE COMMONWEALTH OF MASSACHUSSETS. FORM 990, PART IX, LINE 11G JACCP EDITORS: PROGRAM SERVICE EXPENSES 3,863. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 3,863. SCIENTIFIC EDITORS COMMITTEE: PROGRAM SERVICE EXPENSES 6,853. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 6,853. BOARD OF DIRECTORS: PROGRAM SERVICE EXPENSES 12,668. MANAGEMENT AND GENERAL EXPENSES 67,565. FUNDRAISING EXPENSES 4,223. TOTAL EXPENSES 84,456. DEVELOPMENT EDITORS: PROGRAM SERVICE EXPENSES 118,435. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 118,435. MANUSCRIPT SCIENTIFIC EDITING: PROGRAM SERVICE EXPENSES 154,619. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 154,619. OVERHEAD: PROGRAM SERVICE EXPENSES 33,143. MANAGEMENT AND GENERAL EXPENSES 16,857. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 50,000. AMERICAN COLLEGE OF CLINICAL PHARMACY 13000 W 87TH STREET PKWY LENEXA KS 66215 431183142 PROMOTE QUALITY CLINICAL PHARMACY PRACTICE MO 501(C)(6) N/A 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 AMERICAN COLLEGE OF CLINICAL PHARMACY P 50000 FMV AMERICAN COLLEGE OF CLINICAL PHARMACY C 260420 CASH